Autopsy report · NCT05060315
Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin
Cause of deathFunding or business
“Sponsor Decision”
Life of this trial
- Registered 2 years 3 months before it started.
- Ran for about 1 year 6 months before it stopped.
- 9 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- United Therapeutics
- Sponsor type
- Industry
- Conditions
- Pulmonary Arterial Hypertension
- Interventions
- Remunity Pump for Remodulin
- Participants
- 9
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.